SEH inhibitor-20
Product Specifications
Target
Epoxide Hydrolase
Related Pathways
Metabolism
Bioactivity
SEH inhibitor-20 is a metabolically stable, orally active sEH inhibitor with an IC50 of 0.2 nM. It exhibits significant analgesic and anti-inflammatory properties, making it a promising candidate for researching neuropathic pain.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1059058-01 0.02 mg (E-Coli)
Recombinant Staphylococcus carnosus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C
Ask
View Details MBS1059058-02 0.1 mg (E-Coli)
Recombinant Staphylococcus carnosus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C
Ask
View Details MBS1059058-03 0.02 mg (Yeast)
Recombinant Staphylococcus carnosus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C
Ask
View Details 
MBS1059058-04 0.1 mg (Yeast)
Recombinant Staphylococcus carnosus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C
Ask
View Details MBS1059058-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus carnosus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C
Ask
View Details